✦ LIBER ✦

Phase 2 trial of carboplatin, weekly paclitaxel, and biweekly bevacizumab in patients with unresectable stage IV melanoma : A North Central Cancer Treatment Group study, N047A

✍ Scribed by Domingo G. Perez; Vera J. Suman; Tom R. Fitch; Thomas Amatruda III; Roscoe F. Morton; Shamim Z. Jilani; Costas L. Constantinou; James R. Egner; Lisa A. Kottschade; Svetomir N. Markovic

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 167 KB
Volume: 115
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.23987

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II trial of nab-paclitaxel (ABI-

A phase II trial of nab-paclitaxel (ABI-007) and carboplatin in patients with unresectable stage IV melanoma : A North Central Cancer Treatment Group Study, N057E1

✍ Lisa A. Kottschade; Vera J. Suman; Thomas Amatruda III; Robert R. McWilliams; Ba 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB

Alternating chemotherapy with etoposide

Alternating chemotherapy with etoposide plus cisplatin and topotecan plus paclitaxel in patients with untreated, extensive-stage small cell lung carcinoma : A Phase II trial of the North Central Cancer Treatment Group

✍ James R. Jett; Alan K. Hatfield; Shauna Hillman; Michael D. Bauman; James A. Mai 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 1 views

## Abstract ## BACKGROUND The objective of this study was to test the response rate and toxicity of alternating chemotherapy in previously untreated patients with extensive‐stage small cell lung carcinoma (SCLC). ## METHODS Patients with histologically proven, extensive‐stage SCLC, with a perfor